{{Rsnum
|rsid=9288410
|Gene=MAP2
|Chromosome=2
|position=209633537
|Orientation=plus
|GMAF=0.2929
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MAP2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 20.4 | 79.6
| HCB | 5.9 | 30.4 | 63.7
| JPT | 5.3 | 36.3 | 58.4
| YRI | 61.2 | 32.7 | 6.1
| ASW | 50.9 | 36.8 | 12.3
| CHB | 5.9 | 30.4 | 63.7
| CHD | 4.6 | 40.4 | 55.0
| GIH | 8.9 | 59.4 | 31.7
| LWK | 47.2 | 45.4 | 7.4
| MEX | 3.4 | 43.1 | 53.4
| MKK | 50.0 | 40.3 | 9.7
| TSI | 3.0 | 25.7 | 71.3
| HapMapRevision=28
}}

[http://7thspace.com/headlines/283954/the_neincbi_dbgap_database_genotypes_and_haplotypes_that_may_predispose_to_risk_of_neovascular_age_related_macular_degeneration.html news] 

[[rs572515]] was the most significantly associated with AMD risk (P <10-6).

[[rs9288410]] and [[rs2014307]] (PLEKHA1/HTRA1) on 10q26 were significantly associated with AMD status (P= .03 and P <10-6 respectively). After controlling for smoking history, gender and age, the most significant gene-gene interaction appears to be between [[rs10801575]] (CFH) and [[rs2014307]] (PLEKHA1/HTRA1) (P <10-11).

{{PMID Auto
|PMID=18541031
|Title=The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}